Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musaab Elmamoun

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drugs|April 5, 2018
Role of Methotrexate in the Management of Psoriatic ArthritisMusaab Elmamoun, Vinod Chandran
The Lancet. Rheumatology|January 25, 2024
Psoriatic arthritis in developing and resource-poor countriesAjesh B Maharaj, Vinod Chandran, Musaab Elmamoun, et al.
The Journal of Rheumatology|March 16, 2021
Comparison of Composite Measure Remission Targets in Psoriatic ArthritisFlora Farkas, Natsumi Ikumi, Musaab Elmamoun, et al.
Rheumatology International|February 3, 2011
Ankylosing spondylitis in Ireland: patient access and response to TNF-α blockersAamir Saeed, Mumtaz Khan, Musaab Elmamoun, et al.
The Journal of Rheumatology|November 3, 2018
Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement SetMusaab Elmamoun, Ying Ying Leung, Denis O'Sullivan, et al.
Arthritis Research & Therapy|July 7, 2017
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritisAgnes Szentpetery, Eric Heffernan, Martina Gogarty, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
The Journal of Rheumatology|May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working GroupAlexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual MeetingRichard Holland, William Tillett, Alexis Ogdie, et al.
The Journal of Rheumatology|February 3, 2017
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016Ana-Maria Orbai, Maarten de Wit, Philip J Mease, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drugs|April 5, 2018
Role of Methotrexate in the Management of Psoriatic ArthritisMusaab Elmamoun, Vinod Chandran
The Lancet. Rheumatology|January 25, 2024
Psoriatic arthritis in developing and resource-poor countriesAjesh B Maharaj, Vinod Chandran, Musaab Elmamoun, et al.
The Journal of Rheumatology|March 16, 2021
Comparison of Composite Measure Remission Targets in Psoriatic ArthritisFlora Farkas, Natsumi Ikumi, Musaab Elmamoun, et al.
Rheumatology International|February 3, 2011
Ankylosing spondylitis in Ireland: patient access and response to TNF-α blockersAamir Saeed, Mumtaz Khan, Musaab Elmamoun, et al.
The Journal of Rheumatology|November 3, 2018
Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement SetMusaab Elmamoun, Ying Ying Leung, Denis O'Sullivan, et al.
Arthritis Research & Therapy|July 7, 2017
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritisAgnes Szentpetery, Eric Heffernan, Martina Gogarty, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
The Journal of Rheumatology|May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working GroupAlexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual MeetingRichard Holland, William Tillett, Alexis Ogdie, et al.
The Journal of Rheumatology|February 3, 2017
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016Ana-Maria Orbai, Maarten de Wit, Philip J Mease, et al.
Pageof 2